Deere & Company’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-44,130
Closed -$1.19M 1074
2016
Q2
$1.19M Buy
+44,130
New +$1.21M 0.06% 327
2016
Q1
Sell
-63,162
Closed -$1.83M 1124
2015
Q4
$1.83M Buy
63,162
+808
+1% +$22.4K 0.11% 199
2015
Q3
$1.69M Buy
+62,354
New +$1.77M 0.11% 224
2014
Q4
Sell
-64,564
Closed -$1.54M 1036
2014
Q3
$1.54M Hold
64,564
0.09% 227
2014
Q2
$1.49M Sell
64,564
-2,106
-3% -$46.5K 0.08% 289
2014
Q1
$1.52M Buy
+66,670
New +$1.42M 0.09% 265
2013
Q4
Sell
-77,540
Closed -$1.31M 1041
2013
Q3
$1.31M Buy
+77,540
New +$1.3M 0.07% 309

Other funds holding NVO

Deere & Company's NVO Position: Q3 2016 in Review

Deere & Company sold out of Novo Nordisk (NVO) in Q3 2016, closing a stake of 44,130 shares — an estimated $1.19M sold.

Deere & Company first reported a position in NVO in Q3 2013 and held it in 7 quarters. The position peaked at $1.83M in Q4 2015. 511 funds tracked by Wall St. Rank hold NVO as of Q3 2016.

  • Deere & Company reported no remaining Novo Nordisk position as of Q3 2016 after selling out during the quarter.
  • Deere & Company sold 44,130 Novo Nordisk shares in Q3 2016, an estimated $1.19M.
  • Deere & Company first reported a position in Novo Nordisk in Q3 2013 and held it in 7 quarters.
  • Deere & Company's Novo Nordisk position peaked at $1.83M in Q4 2015.
  • 511 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2016.

Based on Deere & Company's 13F filing for Q3 2016, filed 14 Nov 2016.